VEGF antibody, ELISA kits and recombinant growth factors that exist in several forms

Getting reproducible growth factor work

1. Establish which isoforms your reagent sees. A gene producing several splice variants needs an antibody whose immunogen region is present in the variants you care about. A pan reagent and a variant specific reagent answer different questions and are sold under similar names.
2. Understand which pool the assay measures. Free ligand, total ligand after dissociation, and ligand in complex give very different numbers from the same sample. A kit that does not state which it measures cannot be compared with one that does.
3. Standardise sample handling for the analyte. Platelet release during collection, clotting and freeze thaw all change measured concentrations for several growth factors. Fix the tube type, the processing time and the aliquoting, and keep them constant across a study.
4. Titrate every new lot of recombinant protein. Specific activity varies between lots and between suppliers even at the same nominal mass, because folding, aggregation and carrier protein content differ. Run a dose response with each new lot rather than matching by mass.
5. Choose carrier free or carrier containing deliberately. Carrier protein stabilises dilute preparations and interferes with some downstream applications. Decide which you need and keep it consistent, because switching changes effective concentration.
6. Record lot with every experiment. For this class of reagent, lot is the variable most likely to explain an unexpected result. Recording it costs nothing and is the first thing an investigation needs.

Mass is not activity, even for recombinant EGF or VEGF

A recombinant growth factor is quoted in micrograms and used for its biological effect, and the relationship between the two depends on how much of the preparation is correctly folded and monomeric. A lot with more aggregate delivers less activity at the same mass.

The practical consequence is that dose response should be re established with each lot. Laboratories that do this stop seeing unexplained shifts in their stimulation experiments.

What a measured concentration means

For ligands that circulate partly bound, a measured concentration is a property of the assay as much as of the sample. Comparing across kits, across studies or across matrices without stating the assay is comparing different quantities.

Report the kit, the standard and the sample handling with any concentration. It is the difference between a number someone can use and a number someone will have to repeat.

A nik antibody and a kinase held down by degradation

NIK is continuously degraded until the non canonical pathway is triggered, so a nik antibody reports almost nothing at rest and its appearance is the signal, which is the opposite of how most kinases are read. A proteasome inhibitor or a receptor stimulation is the control that produces the band, and a figure without one cannot distinguish a working antibody from a quiet pathway.

A trpa1 antibody and a channel with a specificity history

TRPA1 antibodies have produced patterns that knockout tissue did not support, so a trpa1 antibody should carry that validation and a peptide block is not a substitute. It is a large multipass channel, so gentle lysis and no boiling apply, and the functional readout with a defined agonist and an antagonist is what most of this literature actually rests on.

A ninj1 antibody and a protein that acts by polymerising

NINJ1 drives membrane rupture in lytic cell death by forming filaments, so a ninj1 antibody is read as oligomerisation and localisation rather than as a level, and a non reducing or crosslinked preparation is what shows the assembled form. Its level does not change during the event, which is why a figure resting on abundance alone reports nothing about the mechanism.

A nod1 antibody and a cytosolic sensor

NOD1 senses bacterial peptidoglycan fragments in the cytosol, so a nod1 antibody reports the sensor while the readout is downstream signalling after a defined ligand, and expression is low in many lines which makes a positive control essential. The family relative shares domains, so specificity against it is the line to read before a tissue conclusion.

Common questions

Why do two human VEGF ELISA kit results give different concentrations?

Because they measure different pools and calibrate against different standards. Neither is necessarily wrong, and the practical response is to choose one kit for a study and report the kit and standard with the values.

Does isoform specificity matter, and is a VEGFA antibody different from a VEGF antibody?

Whenever the biology depends on which isoform is present, which for several growth factor families it does. Check the immunogen region against the isoform structure rather than trusting the gene name on the label.

Why does a new lot of recombinant protein behave differently?

Specific activity differs between lots because of folding, aggregation and carrier content. Titrating each lot against a dose response, rather than matching stated mass, is the only reliable approach.

How should samples be collected for growth factor measurement?

With a fixed tube type, a fixed time to processing and minimal freeze thaw, because several of these analytes are released or degraded during handling. The collection protocol is part of the method.

Browse by service class

• Compare Gene synthesis on advertised prices